Poly(I:C) primes primary human glioblastoma cells for an immune response invigorated by PD-L1 blockade

Prognosis of glioblastoma remains dismal, underscoring the need for novel therapies. Immunotherapy is generating promising results, but requires combination strategies to unlock its full potential. We investigated the immunomodulatory capacities of poly(I:C) on primary human glioblastoma cells and i...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Oncoimmunology
Asıl Yazarlar: De Waele, Jorrit, Marcq, Elly, Van Audenaerde, Jonas RM, Van Loenhout, Jinthe, Deben, Christophe, Zwaenepoel, Karen, Van de Kelft, Erik, Van der Planken, David, Menovsky, Tomas, Van den Bergh, Johan MJ, Willemen, Yannick, Pauwels, Patrick, Berneman, Zwi N, Lardon, Filip, Peeters, Marc, Wouters, An, Smits, Evelien LJ
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Taylor & Francis 2017
Konular:
Original Research
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC5790389/
https://ncbi.nlm.nih.gov/pubmed/29399410
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/2162402X.2017.1407899
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller